Oleoylethanolamide, an endogenous PPAR-α agonist, lowers body weight and hyperlipidemia in obese rats
- 21 April 2005
- journal article
- Published by Elsevier
- Vol. 48 (8) , 1147-1153
- https://doi.org/10.1016/j.neuropharm.2005.02.013
Abstract
No abstract availableKeywords
This publication has 15 references indexed in Scilit:
- Oleoylethanolamide Stimulates Lipolysis by Activating the Nuclear Receptor Peroxisome Proliferator-activated Receptor α (PPAR-α)Journal of Biological Chemistry, 2004
- Oleylethanolamide regulates feeding and body weight through activation of the nuclear receptor PPAR-αNature, 2003
- Modulation of Meal Pattern in the Rat by the Anorexic Lipid Mediator OleoylethanolamideNeuropsychopharmacology, 2003
- The Mechanisms of Action of PPARsAnnual Review of Medicine, 2002
- An anorexic lipid mediator regulated by feedingNature, 2001
- A selective peroxisome proliferator-activated receptor δ agonist promotes reverse cholesterol transportProceedings of the National Academy of Sciences, 2001
- Quantitative Reverse Transcription–Polymerase Chain Reaction to Study mRNA Decay: Comparison of Endpoint and Real-Time MethodsAnalytical Biochemistry, 2000
- The PPARs: From Orphan Receptors to Drug DiscoveryJournal of Medicinal Chemistry, 2000
- Peroxisome Proliferator-Activated Receptors: Nuclear Control of MetabolismEndocrine Reviews, 1999
- Ciglitazone, a new hypoglycemic agent. I. Studies in ob/ob and db/db mice, diabetic Chinese hamsters, and normal and streptozotocin-diabetic ratsDiabetes, 1983